How much funding has Congruence Therapeutics raised?

Congruence Therapeutics has raised $137.0M in total funding, most recently a Series B round.

Who are Congruence Therapeutics's investors?

Congruence Therapeutics's investors include Lumira Ventures, Amplitude Ventures, Fonds de solidarité FTQ, BDC Venture Capital, Investissement Québec, OrbiMed.

When was Congruence Therapeutics founded?

Congruence Therapeutics was founded in 2019.

Where is Congruence Therapeutics headquartered?

Congruence Therapeutics is headquartered in Montreal, Quebec, Canada.

What industry is Congruence Therapeutics in?

Congruence Therapeutics operates in Biotech, Drug Discovery, Therapeutics.

How many employees does Congruence Therapeutics have?

Congruence Therapeutics has 11-50 employees.

Congruence Therapeutics

Home - Congruence

Montreal, Canada · Founded 2019 · $137.0M raised

Biotech

Drug Discovery

Therapeutics

Headquarters: Montreal, Quebec
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: congruencetx.com
Total Funding: $137.0M
Last Round: $40.0M Series BMar 2026
Rounds: 4

About

Congruence Therapeutics is a Montreal-based drug discovery company harnessing protein dynamics, biophysics, machine learning, and computational chemistry to design small-molecule correctors for diseases caused by protein misfolding. Its proprietary Revenir platform models the full conformational ensemble of target proteins.

Summary

Congruence Therapeutics is a Biotech company based in Montreal, Canada, founded in 2019. It has raised $137.0M in total across 4 rounds, most recently a $40.0M Series B round in Mar 2026. Investors include Lumira Ventures, Amplitude Ventures and Fonds de solidarité FTQ.